Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.25 mL Prefilled Syringe
RxNorm 2280752
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2280752 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.25 mL Prefilled Syringe.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
0.25 mL influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 mg/ML / influenza A virus A/South Australia/34/2019 (H3N2) antigen 0.03 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 mg/ML / influenza B virus B/Washington/02/2019 antigen 0.03 mg/ML Prefilled Syringe [Fluzone Quadrivalent 2020 Southern Hemisphere]
(Atom ID: 11832081)
PSN
Prescribable Name (PSN):
Fluzone Quadrivalent 2020 Southern Hemisphere vaccine 0.25 mL Prefilled Syringe
(Atom ID: 11829259)
SY